文献速递神经肿瘤

亚致死剂量照射与替莫唑胺增强胶质瘤细胞侵袭伪足活性

Enhancement of invadopodia activity in glioma cells by sublethal doses of irradiation and temozolomide.
PubMed 文献 · J Neurosurg · 2017-11-17

本研究评估放疗与替莫唑胺对胶质瘤细胞侵袭伪足的影响。结果显示,经放疗和替莫唑胺处理的胶质瘤细胞主要增加MMP-2活化,并显著增强侵袭伪足介导的基质降解能力,且侵袭伪足阳性细胞百分比升高。作者认为治疗后侵袭性增强可能由侵袭伪足介导,其形成或活性或可成为辅助治疗靶点。

要点

  • 胶质瘤细胞表达多种侵袭伪足调控蛋白并分泌MMP-2,形成功能性基质降解侵袭伪足。
  • 放疗和替莫唑胺处理后,胶质瘤细胞主要增加MMP-2活化。
  • 处理后侵袭伪足介导的基质降解能力显著增强,侵袭伪足阳性细胞百分比升高。

核心结论

  • 研究数据提示,既往观察到的胶质瘤细胞治疗后侵袭性增强由侵袭伪足介导。
  • 作者提出,若能破坏侵袭伪足的形成或活性,或可作为与现有方案联用的新型辅助治疗靶点。

研究设计与样本

  • 研究采用多种市售细胞系及来自患者的胶质瘤细胞系,先筛查侵袭伪足调控蛋白表达水平。
  • 用明胶酶谱法建立分泌蛋白酶谱,并以细胞活力、Western印迹、明胶酶谱和侵袭伪足基质降解实验评估放疗与替莫唑胺处理的影响。

主要发现

  • 所用胶质瘤细胞表达多种侵袭伪足调控蛋白,分泌MMP-2,并形成功能性基质降解侵袭伪足。
  • 放疗和替莫唑胺处理后,细胞主要显示MMP-2活化增加。
  • 处理后侵袭伪足介导的基质降解能力显著增强,且侵袭伪足阳性细胞百分比升高。

临床怎么用

  • 作者认为,若侵袭伪足的形成或活性可被破坏,或可作为与现有治疗方案联用的新型辅助治疗策略靶点。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Glioblastoma is the most common primary central nervous system tumor in adults. These tumors are highly invasive and infiltrative and result in tumor recurrence as well as an extremely poor patient prognosis. The current standard of care involves surgery, radiotherapy, and chemotherapy. However, previous studies have suggested that glioblastoma cells that survive treatment are potentially more invasive. The goal of this study was to investigate whether this increased phenotype in surviving cells is facilitated by actin-rich, membrane-based structures known as invadopodia. METHODS A number of commercially available cell lines and glioblastoma cell lines obtained from patients were initially screened for the protein expression levels of invadopodia regulators. Gelatin-based zymography was also used to establish their secretory protease profile. The effects of radiation and temozolomide treatment on the glioblastoma cells were then investigated with cell viability, Western blotting, gelatin-based zymography, and invadopodia matrix degradation assays. RESULTS The authors' results show that the glioma cells used in this study express a number of invadopodia regulators, secrete MMP-2, and form functional matrix-degrading invadopodia. Cells that were treated with radiotherapy and temozolomide were observed to show an increase primarily in the activation of MMP-2. Importantly, this also resulted in a significant enhancement in the invadopodia-facilitated matrix-degrading ability of the cells, along with an increase in the percentage of cells with invadopodia after radiation and temozolomide treatment. CONCLUSIONS The data from this study suggest that the increased invasive phenotype that has been previously observed in glioma cells posttreatment is mediated by invadopodia. The authors propose that if the formation or activity of these structures can be disrupted, they could potentially serve as a viable target for developing novel adjuvant therapeutic strategies that can be used in conjunction with the current treatment protocols in combatting the invasive phenotype of this deadly disease.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Mao L, Whitehead CA, Paradiso L, et al. Enhancement of invadopodia activity in glioma cells by sublethal doses of irradiation and temozolomide. J Neurosurg. 2017. PMID: 29148898. doi:10.3171/2017.5.JNS17845

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。